SFM
DMTX

Sphera Funds Management’s Dimension Therapeutics, Inc DMTX Stock Holding History

Sphera Funds Management’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-200,000
Closed -$2.26M – 141
2015
Q4 		$2.26M Buy
+200,000
New +$2.53M 0.33% 76

Other funds holding DMTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Sphera Funds Management's DMTX Position: Q1 2016 in Review

Sphera Funds Management sold out of Dimension Therapeutics, Inc (DMTX) in Q1 2016, closing a stake of 200,000 shares — an estimated $2.26M sold.

Sphera Funds Management first reported a position in DMTX in Q4 2015 and held it in 1 quarter. The position peaked at $2.26M in Q4 2015. 40 funds tracked by Wall St. Rank hold DMTX as of Q1 2016.

  • Sphera Funds Management reported no remaining Dimension Therapeutics, Inc position as of Q1 2016 after selling out during the quarter.
  • Sphera Funds Management sold 200,000 Dimension Therapeutics, Inc shares in Q1 2016, an estimated $2.26M.
  • Sphera Funds Management first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 1 quarter.
  • Sphera Funds Management's Dimension Therapeutics, Inc position peaked at $2.26M in Q4 2015.
  • 40 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q1 2016.

Based on Sphera Funds Management's 13F filing for Q1 2016, filed 16 May 2016.